QuantuMDx Market Research Officer

Maternity Cover
  • icon
    Position overview:

    As QuantuMDx prepares to launch its flagship product Q-POC™, this role will work within the Product Realisation Team to engage with a range of stakeholders to support the development, roll out of market-driven products, and support the implementation of the Company’s business plan.

    This is a position that will cover the maternity leave of the End User and Market Research Manager. This position is to begin February 2018.  The role will be a short-term contract for 9-12 months, there is a possibility it may become permanent for the correct candidate.

    Key Roles & Responsibilities

    Performs a combination, but not necessarily all, of the following duties:

    • Conduct market and end user research to support customer-centric and market-appropriate product development, including:
      • refinement of the test menu and identification of new market opportunities
      • development of product specifications based on market data and clinical need
      • supporting the management market research sub-contractors ie S2N
      • supporting the Patient Engagement & Training Manager in usability work
    • Inform development of market entry strategies for each assay and its target markets
      • conduct research on the market structure and dynamics, key players and funders
      • support development of a bottom-up revenue model to aid in continuous refinement of the company business plan and product launch strategies
      • aid in identification of clinical, implementation and impact evidence requirements and partners
    • Undertake other tasks as may reasonably be requested from time to time by Senior Management

    Experience, knowledge and requirements
    • Undergraduate degree, preferably in a scientific field
    • Minimum 1 years’ experience in a market research role
    • Demonstrable experience of producing high quality market research reports, including collection and interpretation of data to support business decision-making
    • Proven ability to conduct and analyse user research to inform product development
    • Excellent communication and project management skills
    • Excellent organisational skills and a team player
    • Must be driven and self-motivated
    • Excellent IT skills
    • Eligible to work full time in the UK without restriction
    • Ability to fit into a dynamic team environment
    • Good sense of humour and ability to adapt to a changing environment as the Company matures and moves from the R&D stage into commercialisation

    Experience in supporting development of a business in the scientific, medical or global health industry

    To apply for this role please send a cover letter and CV to hr@quantumdx.com.


    Download the Job Description


    The intent of this job description is to provide a representation and level of the types of duties and responsibilities that will be required of positions given this title and shall not be construed as a declaration of the total of the specific duties and responsibilities of any particular position. Employees may be directed to perform job-related tasks other than those specifically presented in this description.


    Company overview

    QuantuMDx Group is one of the most exciting life sciences, tools and diagnostics companies to emerge from the UK in recent years. Due for commercialisation in 2018, their signature device, Q-POC™, is a low-cost, simple-to-use, portable diagnostic device for 10 – 20 minute diagnosis at the patient’s side. The robust device will identify the presence and strain of an infection, ensuring the right drug is prescribed first time, facilitating a more intelligent use of antibiotics. Further to this, globally distributed Q-POC™ devices will geotag and anonymise pathogen data, sending it to the cloud for real-time disease and drug resistance monitoring, and rapid detection and containment of pathogens.

    Q-POC™ is ideally suited to help address the humanitarian health burden by offering gold-standard molecular diagnostics at a fraction of the price of traditional testing. Once the device has passed regulatory approval it will be available for highly multiplexed diagnostic and drug susceptibility testing for just a few dollars, in any setting globally.